HEOR/Market Access

Enhance product value stories

and make rapid, data-driven decisions

based on novel, market-relevant insights.

Dr.Evidence™ is the medical intelligence platform that enables you to enhance product value stories based on the vast universe of published medical information, real-world evidence and proprietary data, and conduct rapid, fit-to-purpose reviews of the landscape.


Select Use Cases

Search and Continuous Monitoring: Literature, Trials and RWE - Derive actionable, real-time insights from PubMed, ClinicalTrials.gov, WHO trials, global drug labels, EMA documentation, RSS feeds and conference abstracts. Get an immediate snapshot of the quantity and quality of the evidence associated with patient populations, interventions and outcomes. Our proprietary machine learning algorithms indicate whether the information is based on RCTs, RWE, human studies or clinical studies.

Landscape Understanding and Competitive intelligence - Identify and prioritize new therapeutic areas and indication expansion opportunities by rapidly synthesizing the ever-expanding volume of literature. Generate an instant, dynamic landscape assessment with an overview of quantity, quality, top interventions, clinical trial status and more. Capture real-time competitive intelligence and instantly synthesize the evidence you need to rapidly respond and reposition. You can also automate conceptual comparisons of competitive label safety sections to identify key areas of your product’s superiority.

SLR & NMA planning - Reduce time and costs dramatically by making sure SLRs and NMAs are designed optimally, from vendor RFPs to regulatory and payer submission. See real-time updates when new literature is available and uncover early the endpoints, subgroups and effect sizes that are critical to product differentiation.